Nonseminomatous germ cell tumor

Known as: NONSEMINOMATOUS GERM CELL TUMORS, Non-seminomatous germ-cell tumors 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2011
2011
BACKGROUND Men on active surveillance for clinical stage I nonseminomatous germ cell tumor (NSGCT) undergo frequent computed… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
  • table 3
Is this relevant?
Review
2002
Review
2002
Germ cell cancer is the most common malignancy in men aged 15–35 years; 5% of the malignant germ cell tumors are of extragonadal… (More)
  • table 1
  • figure 1
  • table 2
  • table 4
  • figure 2
Is this relevant?
1998
1998
PURPOSE Primary mediastinal nonseminomatous germ cell tumors (NSGCT) are uncommon neoplasms and clinically and biologically… (More)
Is this relevant?
1997
1997
PURPOSE This retrospective study was undertaken to assess the outcome of patients with disseminated nonseminomatous germ cell… (More)
Is this relevant?
Highly Cited
1995
Highly Cited
1995
PURPOSE To develop a statistical model that predicts the histology (necrosis, mature teratoma, or cancer) after chemotherapy for… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
Highly Cited
1993
Highly Cited
1993
BACKGROUND Germ cell tumors are empirically divided into seminomas and nonseminomatous germ cell tumors (NSGCT). Some authorities… (More)
Is this relevant?
Highly Cited
1990
Highly Cited
1990
One hundred eighty-five patients who underwent surgery within 6 months of completing chemotherapy were identified from 360… (More)
Is this relevant?
1990
1990
Between 1976 and 1988, 31 patients with mediastinal nonseminomatous germ cell tumors (MNGCT) received initial cisplatin-based… (More)
Is this relevant?
1990
1990
In men who otherwise seem to have responded to chemotherapy for nonseminomatous germ cell tumors (NSGCTs), enlarging masses can… (More)
Is this relevant?
1986
1986
From April 1975 through May 1981, 51 patients had teratoma resected from residual disease following cisplatin-based combination… (More)
Is this relevant?